Global Clinical Trial Opportunities in Japan (1)



Mohamed Oubihi
01/07/2014

Abstract: Since 2007, Japan has been engaged in a sweeping wave of reforms covering the pharmaceutical regulatory environment and the clinical trial infrastructure in order to enable a swift execution of global clinical trials in Japan and eradicate the onerous “drug lag problem” ie delay between launch of a drug in the West (EU/US) and Japan. This first article is an introduction to some unique features of Japanese clinical trial environment and the changes that have been ongoin...
TO READ THE FULL STORY